Skip to main content
Top
Published in: Virology Journal 1/2015

Open Access 01-12-2015 | Research

Detection of human parvovirus 4 viremia in the follow-up blood samples from seropositive individuals suggests the existence of persistent viral replication or reactivation of latent viral infection

Authors: Mao-Yuan Chen, Chien-Ching Hung, Kuang-Lun Lee

Published in: Virology Journal | Issue 1/2015

Login to get access

Abstract

Background

The transmission routes for human parvovirus 4 (PARV4) infections in areas with high seroprevalence are not known. In the work described here, persistent PARV4 viral replication was investigated by conducting a longitudinal study.

Methods

Ten healthcare workers each provided a blood sample at the beginning of the study (first sample) and 12 months later (second sample). The paired samples were tested for PARV4-positivity by immunoblotting analysis and nested polymerase chain reactions.

Results

IgG antibodies against PARV4 were detected in six participants, three of whom also had IgM antibodies against PARV4. The immunoblotting results did not vary over time. PARV4 DNA was detected in the first blood sample from one participant who had IgG antibodies against PARV4 and in the second blood samples from 2 participants who had IgG and IgM antibodies against PARV4.

Conclusions

Detection of PARV4 DNA in the second blood samples from two seropositive participants suggests the existence of persistent PARV4 replication or reactivation of inactive virus in the tissues. The finding of persistent or intermittent PARV4 replication in individuals with past infections provides an important clue toward unraveling the non-parenteral transmission routes of PARV4 infection in areas where the virus is endemic.
Literature
1.
go back to reference Brown KE. The expanding range of parvoviruses which infect humans. Rev Med Virol. 2010;20:231–44.PubMedCrossRef Brown KE. The expanding range of parvoviruses which infect humans. Rev Med Virol. 2010;20:231–44.PubMedCrossRef
2.
go back to reference Jones MS, Kapoor A, Lukashov VV, Simmonds P, Hecht F, Delwart E. New DNA viruses identified in patients with acute viral infection syndrome. J Virol. 2005;79:8230–6.PubMedCentralPubMedCrossRef Jones MS, Kapoor A, Lukashov VV, Simmonds P, Hecht F, Delwart E. New DNA viruses identified in patients with acute viral infection syndrome. J Virol. 2005;79:8230–6.PubMedCentralPubMedCrossRef
3.
go back to reference Sharp CP, Vermeulen M, Nébié Y, Djoko CF, LeBreton M, Tamoufe U, et al. Epidemiology of human parvovirus 4 infection in Sub-Saharan Africa. Emerg Infect Dis. 2010;16:1605–7.PubMedCentralPubMedCrossRef Sharp CP, Vermeulen M, Nébié Y, Djoko CF, LeBreton M, Tamoufe U, et al. Epidemiology of human parvovirus 4 infection in Sub-Saharan Africa. Emerg Infect Dis. 2010;16:1605–7.PubMedCentralPubMedCrossRef
4.
go back to reference Sharp CP, Lail A, Donfield S, Simmons R, Leen C, Klenerman P, et al. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies. J Infect Dis. 2009;200:1119–25.PubMedCentralPubMedCrossRef Sharp CP, Lail A, Donfield S, Simmons R, Leen C, Klenerman P, et al. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies. J Infect Dis. 2009;200:1119–25.PubMedCentralPubMedCrossRef
5.
go back to reference Lahtinen A, Kivelä P, Hedman L, Kumar A, Kantele A, Lappalainen M, et al. Serodiagnosis of primary infections with human parvovirus 4 Finland. Emerg Infect Dis. 2011;17:79–82.PubMedCentralPubMedCrossRef Lahtinen A, Kivelä P, Hedman L, Kumar A, Kantele A, Lappalainen M, et al. Serodiagnosis of primary infections with human parvovirus 4 Finland. Emerg Infect Dis. 2011;17:79–82.PubMedCentralPubMedCrossRef
6.
go back to reference Tamošiūnas PL, Simutis K, Kodzė I, Firantienė R, Emužytė R, Petraitytė-Burneikienė R, et al. Production of human parvovirus 4 VP2 virus-like particles in yeast and their evaluation as an antigen for detection of virus-specific antibodies in human serum. Intervirology. 2013;56:271–7.PubMedCrossRef Tamošiūnas PL, Simutis K, Kodzė I, Firantienė R, Emužytė R, Petraitytė-Burneikienė R, et al. Production of human parvovirus 4 VP2 virus-like particles in yeast and their evaluation as an antigen for detection of virus-specific antibodies in human serum. Intervirology. 2013;56:271–7.PubMedCrossRef
7.
go back to reference Maple PAC, Beard S, Parry RP, Brown KE. Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and western blot to confirm reactive samples. Transfusion. 2013;53:2575–84.PubMedCrossRef Maple PAC, Beard S, Parry RP, Brown KE. Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and western blot to confirm reactive samples. Transfusion. 2013;53:2575–84.PubMedCrossRef
8.
go back to reference Lefrère JJ, Servant-Delmas A, Candotti D, Mariotti M, Thomas I, Brossard Y, et al. Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood. 2005;106:2890–5.PubMedCrossRef Lefrère JJ, Servant-Delmas A, Candotti D, Mariotti M, Thomas I, Brossard Y, et al. Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood. 2005;106:2890–5.PubMedCrossRef
9.
go back to reference Norja P, Hokynar K, Aaltonen LM, Chen R, Ranki A, Partio EK, et al. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA. 2006;103:7450–3.PubMedCentralPubMedCrossRef Norja P, Hokynar K, Aaltonen LM, Chen R, Ranki A, Partio EK, et al. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA. 2006;103:7450–3.PubMedCentralPubMedCrossRef
10.
go back to reference Simmons R, Sharp C, Levine J, Bowness P, Simmonds P, Cox A, et al. Evolution of CD8+ T cell responses after acute PARV4 infection. J Virol. 2013;87:3087–96.PubMedCentralPubMedCrossRef Simmons R, Sharp C, Levine J, Bowness P, Simmonds P, Cox A, et al. Evolution of CD8+ T cell responses after acute PARV4 infection. J Virol. 2013;87:3087–96.PubMedCentralPubMedCrossRef
11.
go back to reference Schneider B, Fryer JF, Reber U, Fischer HP, Tolba RH, Baylis SA, et al. Persistence of novel human parvovirus PARV4 in liver tissue of adults. J Med Virol. 2008;80:345–51.PubMedCrossRef Schneider B, Fryer JF, Reber U, Fischer HP, Tolba RH, Baylis SA, et al. Persistence of novel human parvovirus PARV4 in liver tissue of adults. J Med Virol. 2008;80:345–51.PubMedCrossRef
12.
go back to reference Corcioli F, Zakrzewska K, Fanci R, De Giorgi V, Innocenti M, Rotellini M, et al. Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V). Virol J. 2010;7:272–6.PubMedCentralPubMedCrossRef Corcioli F, Zakrzewska K, Fanci R, De Giorgi V, Innocenti M, Rotellini M, et al. Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V). Virol J. 2010;7:272–6.PubMedCentralPubMedCrossRef
13.
go back to reference Manning A, Willey SJ, Bell JE, Simmonds P. Comparison of tissue distribution, persistence and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J Infect Dis. 2007;195:1345–52.PubMedCrossRef Manning A, Willey SJ, Bell JE, Simmonds P. Comparison of tissue distribution, persistence and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J Infect Dis. 2007;195:1345–52.PubMedCrossRef
14.
go back to reference Candotti D, Etiz N, Parsyan A, Allain JP. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol. 2004;22:12169–78.CrossRef Candotti D, Etiz N, Parsyan A, Allain JP. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol. 2004;22:12169–78.CrossRef
15.
go back to reference Fryer JF, Delwart E, Hecht FM, Bernardin F, Jones MS, Shah N, et al. Frequent detection of the parvoviruses, PAR4 and PARV5, in plasma from blood donors and symptomatic individuals. Transfusion. 2007;47:1054–61.PubMedCrossRef Fryer JF, Delwart E, Hecht FM, Bernardin F, Jones MS, Shah N, et al. Frequent detection of the parvoviruses, PAR4 and PARV5, in plasma from blood donors and symptomatic individuals. Transfusion. 2007;47:1054–61.PubMedCrossRef
16.
go back to reference Simmons R, Sharp C, Sims S, Kloverpris H, Goulder P, Simmonds P, et al. High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo. J Infect Dis. 2011;203:1378–87.PubMedCentralPubMedCrossRef Simmons R, Sharp C, Sims S, Kloverpris H, Goulder P, Simmonds P, et al. High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo. J Infect Dis. 2011;203:1378–87.PubMedCentralPubMedCrossRef
17.
go back to reference Yang SJ, Hung CC, Chang SY, Lee KL, Chen MY. Immunoglobulin G and M antibodies to human Parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 Infection. J Clin Virol. 2011;51:64–7.PubMedCrossRef Yang SJ, Hung CC, Chang SY, Lee KL, Chen MY. Immunoglobulin G and M antibodies to human Parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 Infection. J Clin Virol. 2011;51:64–7.PubMedCrossRef
18.
go back to reference Lou S, Xu B, Huang Q, Zhi N, Cheng F, Wong S, et al. Molecular characterization of the newly identified human parvovirus 4 in the family parvoviridae. Virol. 2012;422:59–69.CrossRef Lou S, Xu B, Huang Q, Zhi N, Cheng F, Wong S, et al. Molecular characterization of the newly identified human parvovirus 4 in the family parvoviridae. Virol. 2012;422:59–69.CrossRef
19.
go back to reference Söderlund M, Brown CS, Spaan WJM, Hedman L, Hedman K. Epitope type-specific IgG response to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis. 1995;172:1431–6.PubMedCrossRef Söderlund M, Brown CS, Spaan WJM, Hedman L, Hedman K. Epitope type-specific IgG response to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis. 1995;172:1431–6.PubMedCrossRef
20.
21.
go back to reference Panning M, Kobbe R, Volbach S, Drexler JF, Adjei S, Adjei O, et al. Novel human parvovirus 4 genotype 3 in infants, Ghana. Emerg Infect Dis. 2010;16:1143–6.PubMedCentralPubMedCrossRef Panning M, Kobbe R, Volbach S, Drexler JF, Adjei S, Adjei O, et al. Novel human parvovirus 4 genotype 3 in infants, Ghana. Emerg Infect Dis. 2010;16:1143–6.PubMedCentralPubMedCrossRef
Metadata
Title
Detection of human parvovirus 4 viremia in the follow-up blood samples from seropositive individuals suggests the existence of persistent viral replication or reactivation of latent viral infection
Authors
Mao-Yuan Chen
Chien-Ching Hung
Kuang-Lun Lee
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2015
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-015-0326-0

Other articles of this Issue 1/2015

Virology Journal 1/2015 Go to the issue